Lifeboat Foundation

Fascinating findings: “1. Neurofeedback yields significant reductions in parent ratings of inattentive and hyperactive-impulsive symptoms. 2. These reductions persist for up to 2–12 months after neurofeedback ends. 3. Although medication has a larger initial effect, symptom reductions resulting from neurofeedback and medication may be comparable over a more extended time period.”

In neurofeedback treatment for ADHD, individuals learn to alter their typical pattern of brainwave activity, i.e., EEG activity, to one that is consistent with a focused and attentive state.

This is done by collecting EEG data from individuals as they focus on stimuli presented on a computer screen. Their ability to control the stimuli, e.g., keeping the smile on a smiley face keeping a video playing, depends on their maintaining an EEG state that reflects focused attention.

Continue reading “Meta-analysis finds sustained benefits of neurofeedback for kids with ADHD” »

(HealthDay)—Get up off of the couch: Sitting too much may kill you even if you exercise regularly.

If you sit for six hours a day or more, your risk of dying early jumps 19 percent, compared with people who sit fewer than three hours, an American Cancer Society study suggests.

And, the study authors added, sitting may kill you in 14 ways, including: cancer; heart disease; stroke; diabetes; kidney disease; suicide; chronic obstructive pulmonary disease (COPD); lung disease; liver disease; peptic ulcer and other digestive disease; Parkinson’s disease; Alzheimer’s disease; nervous disorders; and musculoskeletal disorders.

What else do you think is hiding up there?

Astrocyte activation in the hippocampus is sufficient to generate synaptic potentiation, enhance memory allocation, and improve cognitive performance beyond what can be achieved by elevating neuronal activity alone.

Living in a culture dependant upon caffeine and lack of sleep, its important to remember that sleep offers an incredibly important biological function. One night of sleep deprivation is tied to Alzheimer’s disease.

While people once believed that sleep was merely a period of inactivity and rest, modern studies in chronobiology have shown that sleep is important for a variety of biochemical processes. A recent study suggests that sleep is even more important than physicians and scientists previously thought, allowing the brain to flush out toxic chemicals that build up over the course of a day.

Neurotoxins and Your Brain

Continue reading “Neurotoxins and Sleep: What You Need to Know” »

Maryam shanechi, university of southern california.

With recent technological advances, we can now record neural activity from the brain, and manipulate this activity with electrical or optogenetic stimulation in real time. These capabilities have brought the concept of brain-machine interfaces (BMI) closer to clinical viability than ever before. BMIs are systems that monitor and interact with the brain to restore lost function, treat neurological disorders, or enhance human performance.

Continue reading “The State of Brain-Machine Interfaces” »

Polio was a devastating disease before the development of the polio vaccine. But now, this once-feared virus might help treat another deadly illness — brain cancer.

In a new study, some patients who had an aggressive type of brain cancer called glioblastoma and who received a genetically modified poliovirus lived much longer than typical for these patients.

The study found that about 21 percent of the brain cancer patients who received the poliovirus therapy were alive three years later. In contrast, among a group of previously treated patients who had the same cancer but received standard therapies (such as chemotherapy), just 4 percent were alive after three years.

Continue reading “Once-Dreaded Poliovirus Could Treat Brain Cancer” »

Does anyone have an opinion on this latest finding?

In the largest-ever study of its kind, researchers combined genomic data from nearly 900,000 patients and healthy individuals to identify commonalities among 10 mental illnesses.

Dreeming big.

Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation and Bpifrance (press release):

“Dreem, a neurotechnology company, today announced the closing of a new round of funding, raising $35 million USD to rapidly accelerate product development, invest in strategic research and development, and advance the future of sleep technology. Last year, Dreem introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The Dreem headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.

Continue reading “Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance” »